This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEI7A04J_L.jpg
The French drugmaker, based in southwest France, expects its revenues for the year to reach between 340 million euros and 360 million euros ($369.90 million), against its earlier forecast of 430 million euros and 590 million euros.
($1 = 0.9732 euros)
